Speaker :

Dr. M Vamshi Krishna, Medical Oncologist, Hyderabad

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

Author: Dennis J. Slamon 

 Citation: N Engl J Med 2020; 382:514-524

Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus  standard-of-care chemotherapy in women with hormone receptor-positive,  HER2-positive advanced breast cancer (monarcHER): a randomised, open-label,   phase 2 trial 

Author: Sara M. Tolaney

 Citation: The Lancet VOLUME 21, ISSUE 6, P763-775, JUNE 01, 2020

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Author: Kimberly H Allison

 Citation: J Clin Oncol.2020 Apr 20;38(12):1346-1366